DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BAY-1093884
2
Unknown
Investigational
Unknown
Unknown
Hemophilia A; Hemophilia B
Tissue factor pathway inhibitor inhibitor
BAY-1093884
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-112
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
R-112
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTOPRAZINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTOPRAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
510M006KO6
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O2
Molecular Weight:
220.27
AlogP:
0.87
PSA:
33.73
HBD:
1.0
HBA:
#RotB:
1.0
Source:
REVAMILAST
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Asthma
Unknown
REVAMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
30LE65637T
Molecule Type:
Small molecule
Molecular Formula:
C18H9Cl2F2N3O4
Molecular Weight:
440.19
AlogP:
4.77
PSA:
91.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BI-836826
2
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse
Leukocyte antigen CD37 inhibitor
BI-836826
×
Maximum Phase:
2
First Approval:
None
UNII:
LB090AB8DB
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOZULERISTIDE
2
Protein
Investigational
Unknown
Unknown
Breast Neoplasms; Glioma; Sarcoma; Skin Neoplasms; Central Nervous System Neoplasms
Unknown
TOZULERISTIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
835UH424TU
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALAGEBRIUM CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Hypertension
Unknown
ALAGEBRIUM CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
79QS8K2877
Molecule Type:
Small molecule
Molecular Formula:
C13H14ClNOS
Molecular Weight:
267.78
AlogP:
2.54
PSA:
20.95
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FULACIMSTAT
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Heart Failure; Myocardial Infarction
Chymase inhibitor
FULACIMSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
VIR72PP4ZU
Molecule Type:
Small molecule
Molecular Formula:
C23H16F3N3O6
Molecular Weight:
487.39
AlogP:
2.7
PSA:
116.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ENOBLITUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Melanoma; Carcinoma, Squamous Cell; Prostatic Neoplasms, Castration-Resistant
CD276 antigen cross-linking agent
ENOBLITUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
M6030H73N9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACRIDINE
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Lung Neoplasms
DNA disrupting agent
ACRIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
42NI1P5Q1X
Molecule Type:
Small molecule
Molecular Formula:
C13H9N
Molecular Weight:
179.22
AlogP:
3.39
PSA:
12.89
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ROVAZOLAC
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Unknown
ROVAZOLAC
×
Maximum Phase:
2
First Approval:
None
UNII:
W51K389XIL
Molecule Type:
Small molecule
Molecular Formula:
C21H19F3N2O4S
Molecular Weight:
452.45
AlogP:
4.2
PSA:
78.26
HBD:
0.0
HBA:
#RotB:
6.0
Source:
LY2828360
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Cannabinoid CB2 receptor agonist
LY2828360
×
Maximum Phase:
2
First Approval:
None
UNII:
O12H7VFU6P
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LISOFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Unknown
LISOFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
L1F2Q2X956
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
280.33
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
REMLARSEN
2
Oligonucleotide
Investigational
Unknown
Unknown
Keloid
Unknown
REMLARSEN
×
Maximum Phase:
2
First Approval:
None
UNII:
X2MD0LH19A
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CELGOSIVIR
2
Small molecule
Investigational
Unknown
Unknown
Dengue; Hepatitis C, Chronic
Alpha glucosidase inhibitor
CELGOSIVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
895VG117HN
Molecule Type:
Small molecule
Molecular Formula:
C12H21NO5
Molecular Weight:
259.3
AlogP:
-1.13
PSA:
90.23
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VRC-01
2
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
VRC-01
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBOXETINE MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
REBOXETINE MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
L94J81YNNY
Molecule Type:
Small molecule
Molecular Formula:
C20H27NO6S
Molecular Weight:
409.5
AlogP:
3.19
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BEDORADRINE SULFATE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Asthma; Status Asthmaticus
Beta-2 adrenergic receptor agonist
BEDORADRINE SULFATE
×
Maximum Phase:
2
First Approval:
None
UNII:
P875C0DV2V
Molecule Type:
Small molecule
Molecular Formula:
C48H66N4O14S
Molecular Weight:
955.14
AlogP:
1.57
PSA:
102.26
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ALECSAT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ALECSAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALBITIAZOLIUM BROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
ALBITIAZOLIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3AC0AJ4ILP
Molecule Type:
Small molecule
Molecular Formula:
C24H42Br2N2O2S2
Molecular Weight:
614.55
AlogP:
4.67
PSA:
48.22
HBD:
2.0
HBA:
#RotB:
17.0
Source:
SUCRALOSE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SUCRALOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
96K6UQ3ZD4
Molecule Type:
Small molecule
Molecular Formula:
C12H19Cl3O8
Molecular Weight:
397.64
AlogP:
-1.66
PSA:
128.84
HBD:
5.0
HBA:
#RotB:
5.0
Source:
AZD-1236
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase 12 inhibitor
AZD-1236
×
Maximum Phase:
2
First Approval:
None
UNII:
B4OQY51WZS
Molecule Type:
Small molecule
Molecular Formula:
C15H19ClN4O5S
Molecular Weight:
402.86
AlogP:
0.51
PSA:
117.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
INSULIN TREGOPIL
2
Protein
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus
Unknown
INSULIN TREGOPIL
×
Maximum Phase:
2
First Approval:
None
UNII:
3UYC0OZ5ON
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
F-652
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
F-652
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NETOGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma modulator
NETOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
QOV2JZ647A
Molecule Type:
Small molecule
Molecular Formula:
C21H16FNO3S
Molecular Weight:
381.43
AlogP:
4.45
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AFABICIN
2
Small molecule
Investigational
Unknown
Unknown
Infections
Enoyl-[acyl-carrier-protein] reductase [NADPH] inhibitor
AFABICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DMM8663H2R
Molecule Type:
Small molecule
Molecular Formula:
C23H24N3O7P
Molecular Weight:
485.43
AlogP:
3.15
PSA:
133.41
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ASCRINVACUMAB
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms; Carcinoma, Hepatocellular; Mesothelioma
Serine/threonine-protein kinase receptor R3 inhibitor
ASCRINVACUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
716FQ5REVO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-582949
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis; Vascular Diseases
MAP kinase p38 alpha inhibitor
BMS-582949
×
Maximum Phase:
2
First Approval:
None
UNII:
CR743OME9E
Molecule Type:
Small molecule
Molecular Formula:
C22H26N6O2
Molecular Weight:
406.49
AlogP:
3.12
PSA:
100.42
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GEMCABENE
2
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Lipid Metabolism Disorders; Non-alcoholic Fatty Liver Disease
Unknown
GEMCABENE
×
Maximum Phase:
2
First Approval:
None
UNII:
B96UX1DDKS
Molecule Type:
Small molecule
Molecular Formula:
C16H30O5
Molecular Weight:
302.41
AlogP:
3.57
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
12.0
Source:
MILK THISTLE
2
Unknown
Investigational
Unknown
Unknown
Colonic Neoplasms; HIV Infections; Diabetic Nephropathies; Gambling; Hepatitis C, Chronic; Renal Insufficiency, Chronic; Trichotillomania
Unknown
MILK THISTLE
×
Maximum Phase:
2
First Approval:
None
UNII:
U946SH95EE
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASP8273
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP8273
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986020
2
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Scleroderma, Localized
Lysophosphatidic acid receptor Edg-2 antagonist
BMS-986020
×
Maximum Phase:
2
First Approval:
None
UNII:
38CTP01B4L
Molecule Type:
Small molecule
Molecular Formula:
C29H26N2O5
Molecular Weight:
482.54
AlogP:
6.74
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RECOMBINANT CD40-LIGAND
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RECOMBINANT CD40-LIGAND
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LYSERGIDE
2
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder, Major; Pain
Unknown
LYSERGIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
8NA5SWF92O
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O
Molecular Weight:
323.44
AlogP:
2.91
PSA:
39.34
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RIPASUDIL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RIPASUDIL
×
Maximum Phase:
2
First Approval:
None
UNII:
11978226XX
Molecule Type:
Small molecule
Molecular Formula:
C15H18FN3O2S
Molecular Weight:
323.39
AlogP:
1.75
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
196
197
198
199
200
201
202
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA